Pleiotropic effects of the HMG-CoA reductase inhibitors

References

• PignoneMPhillipsCMulrowCUse of lipid lowering drugs for primary prevention of coronary heart disease: Meta-analysis of randomized trialsBMJ200032198398511039962
   PubMed Web of Science ®Google Scholar
• TonkinAAylwardPColquhounDPrevention of cardiovascular events and death with pravastatin in patients with coronary heart disease and a broad range of initial cholesterol levels. The Long-Term Intervention with Pravastatin in Ischaemic Disease (LIPID) study groupN Engl J Med1998339134913579841303
   PubMed Web of Science ®Google Scholar
• EndresMStatins and strokeJ Cereb Blood Flow Metab2005251093111015815580
   PubMed Web of Science ®Google Scholar
• LiaoJKBeyond lipid lowering: The role of statins in vascular protectionInt J Cardiol20028651812243846
   PubMed Web of Science ®Google Scholar
• LiJLiJJHeJGNanJLGuoYLXiongCMAtorvastatin decreases C-reactive protein-induced inflammatory response in pulmonary artery smooth muscle cells by inhibiting nuclear factor-kappa B pathwayCardiovasc Ther20102881420074254
   PubMed Web of Science ®Google Scholar
• TandonVBanoGKhajuriaVPariharAGuptaSPleiotropic effects of statinsIndian J Pharmacol2005377785
   Google Scholar
• ClelandJGMcMurrayJJKjekshusJPlasma concentration of amino-terminal pro-brain natriuretic peptide in chronic heart failure: Prediction of cardiovascular events and interaction with the effects of rosuvastatin. A report from CORONA (Controlled Rosuvastatin Multinational Trial in Heart Failure)J Am Coll Cardiol2009541850185919892235
   PubMed Web of Science ®Google Scholar
• BarriosVEscobarERosuvastatin along the cardiovascular continuum: From JUPITER to AURORAExpert Rev Cardiovasc Ther200971317132719900015
   PubMedGoogle Scholar
• McMurrayJJKjekshusJGullestadLEffects of statin therapy according to plasma high-sensitivity C-reactive protein concentration in the controlled rosuvastatin multinational trial in heart failure (CORONA): A retrospective analysisCirculation20091202188219619917888
   PubMed Web of Science ®Google Scholar
• KjeshkusJApreteiEBarriosVRosuvastatin in older patients with systolic heart failureN Engl J Med200735722482246117984166
   PubMed Web of Science ®Google Scholar
• OkazakiHStatin prevents structural and electrical remodeling in rat hypertensive heart failure induced by chronic inhibition of NO synthesisCirculation2007116SupplII140
   Google Scholar
• KumagaiKNakashimaHSakuKThe HMG-CoA reductase inhibitor atorvastatin prevents atrial fibrillation by inhibiting inflammation in a canine sterile pericarditis modelCardiovasc Res20046210511115023557
   PubMed Web of Science ®Google Scholar
• Young-XuYJabbourSGoldbergRUsefulness of statin drugs in protecting against atrial fibrillation in patients with coronary artery diseaseAm J Cardiol2003921379138314675569
   PubMed Web of Science ®Google Scholar
• KulikASinghJPLevinRAvornJChoudhryNKAssociation between statin use and the incidence of atrial fibrillation following hospitalization for coronary artery diseaseAm J Cardiol20101051655166020538110
   PubMed Web of Science ®Google Scholar
• SiuCLauCTseHPrevention of atrial fibrillation recurrence by statin therapy in patients with lone atrial fibrillation after successful cardioversionAm J Cardiol2003921343134514636918
   PubMed Web of Science ®Google Scholar
• SunYFMeiYQJiQEffect of atorvastatin on postoperative atrial fibrillation in patients undergoing coronary artery bypass graftingZhonghua Yi Xue Za Zhi20098929882991 Chinese.20137710
   PubMedGoogle Scholar
• VedreAGurmHFroehlichJImpact of prior statin therapy on arrhythmic events in patients with acute coronary syndromes (from the Global Registry of Acute Coronary Events [GRACE])Am J Cardiol20091041613161719962463
   PubMed Web of Science ®Google Scholar
• ChiuJHAbdelhadiRHChungMKEffect of statin therapy on risk of ventricular arrhythmia among patients with coronary artery disease and an implantable cardioverter-defibrillatorAm J Cardiol20059549049115695135
   PubMed Web of Science ®Google Scholar
• VyasAKGuoHMossAJReduction in ventricular tachyarrhythmias with statins in the Multicenter Automatic Defibrillator Implantation Trial (MADIT) IIJ Am Coll Cardiol20064776977316487843
   PubMed Web of Science ®Google Scholar
• KimJSKimJChoiDEfficacy of high-dose atorvastatin loading before primary percutaneous coronary intervention in ST-segment elevation myocardial infarction: The STATIN STEMI trialJACC Cardiovasc Interv2010333233920298994
   PubMed Web of Science ®Google Scholar
• PasceriVPattiGNuscaAPristipinoCRichichiGDi SciascioGRandomized trial of atorvastatin for reduction of myocardial damage during coronary intervention: Results from the ARMYDA (Atorvastatin for Reduction of MYocardial Damage during Angioplasty) trialCirculation200411067467815277322
   PubMed Web of Science ®Google Scholar
• CaySCagirciGSenNBalbayYDurmazTAydogduSPrevention of peri-procedural myocardial injury using a single high loading dose of rosuvastatinCardiovasc Drugs Ther201024414720217203
   PubMed Web of Science ®Google Scholar
• YunKHOhSKRheeSJYooNJKimNHJeongJW12-month follow-up results of high dose rosuvastatin loading before percutaneous coronary intervention in patients with acute coronary syndromeInt J Cardiol2011146687220471117
   PubMed Web of Science ®Google Scholar
• RidkerPMMorrowDARoseLMRifaiNCannonCPBraunwaldERelative efficacy of atorvastatin 80 mg and pravastatin 40 mg in achieving the dual goals of low-density lipoprotein cholesterol <70 mg/dl and C-reactive protein <2 mg/l: An analysis of the PROVE-IT TIMI-22 trialJ Am Coll Cardiol2005451644164815893181
   PubMed Web of Science ®Google Scholar
• GibsonCMPrideYBHochbergCPSloanSSabatineMSCannonCPEffect of intensive statin therapy on clinical outcomes among patients undergoing percutaneous coronary intervention for acute coronary syndrome. PCI-PROVE IT: A PROVE IT-TIMI 22 (Pravastatin or Atorvastatin Evaluation and Infection Therapy-Thrombolysis In Myocardial Infarction 22) substudyJ Am Coll Cardiol2009542290229519958964
   PubMed Web of Science ®Google Scholar
• Di SciascioGPattiGPasceriVGaspardoneAColonnaGMontinaroAEfficacy of atorvastatin reload in patients on chronic statin therapy undergoing percutaneous coronary intervention: Results from the ARMYDA-RECAPTURE (Atorvastatin for Reduction of MYocardial Damage during Angioplasty) randomized trialJ Am Coll Cardiol20095455856519643320
   PubMed Web of Science ®Google Scholar
• NovaroGMTiongIYPearceGLEffect of hydroxymethylglutaryl coenzyme A reductase inhibitors on the progression of calcific aortic stenosisCirculation20011042205220911684632
   PubMed Web of Science ®Google Scholar
• AronowWSAhnCKronzonIAssociation of coronary risk factors and use of statins with progression of mild valvular stenosis in older personsAm J Cardiol20018869369511564402
   PubMed Web of Science ®Google Scholar
• BellamyMFPellikkaPAKlarichKWAssociation of cholesterol levels, hydroxymethylglutaryl coenzyme A reductase inhibitor treatment, and progression of aortic stenosis in the communityJ Am Coll Cardiol2002401723173012446053
   PubMed Web of Science ®Google Scholar
• MouraLMRamosSFZamoranoJLRosuvastatin affecting aortic valve endothelium to slow the progression of aortic stenosisJ Am Coll Cardiol20074955456117276178
   PubMed Web of Science ®Google Scholar
• PagovichOWangELee-WongMStatins may improve asthmaJ Allergy Clin Immunol2010125 Abstr 178.
   Web of Science ®Google Scholar
• StanekEAubertRXiaFStatin exposure reduces the risk of asthma-related hospitalizations and emergency room visits in asthmatic patients on inhaled corticosteroidsJ Allergy Clin Immunol2009123 Abstr 238.
   Web of Science ®Google Scholar
• BlamounAIBattyGNDeBariVARashidAOSheikhMKhanMAStatins may reduce episodes of exacerbation and the requirement for intubation in patients with COPD: Evidence from a retrospective cohort studyInt J Clin Pract2008621373137818422598
   PubMed Web of Science ®Google Scholar
• MortensenEMCopelandLAPughMJImpact of statins and ACE inhibitors on mortality after COPD exacerbationsRespir Res2009101919134192
   PubMed Web of Science ®Google Scholar
• AlexeeffSELitonjuaAASparrowDVokonasPSSchwartzJStatin use reduces decline in lung function: VA Normative Aging StudyAm J Respir Crit Care Med200717674274717673694
   PubMed Web of Science ®Google Scholar
• KeddissiJIYounisWGChbeirEADaherNNDernaikaTAKinasewitzGTThe use of statins and lung function in current and former smokersChest20071321764177117908708
   PubMed Web of Science ®Google Scholar
• ParikhAChildressCDeitrickKLinQRukstalisDYangWStatin-induced autophagy by inhibition of geranylgeranyl biosynthesis in prostate cancer PC3 cellsProstate20107097198120135644
   PubMed Web of Science ®Google Scholar
• KatzMSCarrollPRCowanJEChanJMD’AmicoAVAssociation of statin and nonsteroidal anti-inflammatory drug use with prostate cancer outcomes: Results from CaPSUREBJU Int201010662763220151961
   PubMed Web of Science ®Google Scholar
• GuttRTolnaarNKunnavakkamRKarrisonTWeichselbaumRRLiauwSLStatin use and the risk of prostate cancer recurrence in men treated with radiation therapyJ Clin Oncol2010282653265920421534
   PubMed Web of Science ®Google Scholar
• BanezLLKlinkJCJayachandranJAssociation between statins and prostate tumor inflammatory infiltrate in men undergoing radical prostactectomyCancer Epidemiol Biomarkers Prev20101972272820160265
   PubMed Web of Science ®Google Scholar
• ChoSJKimJSKimJMLeeYJJungJSSongISSimvastatin induces apoptosis in human colon cancer cells and in tumor xenografts, and attenuates colitis-associated colon cancer in miceInt J Cancer200812395195718521906
   PubMed Web of Science ®Google Scholar
• KanekoRTsujiNAsanumaKTanebeHKobayashiDWatanabeNSurvivin down-regulation plays a crucial role in 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitor-induced apoptosis in cancerJ Biol Chem2007282192731928117472962
   PubMed Web of Science ®Google Scholar
• AgarwalBBhendwalSHalmosBMossSFRameyWGHoltPRLovastatin augments apoptosis induced by chemotherapeutic agents in colon cancer cellsClin Cancer Res199952223222910473109
   PubMed Web of Science ®Google Scholar
• PoynterJNGruberSBHigginsPDStatins and the risk of colorectal cancerN Engl J Med20053522184219215917383
   PubMed Web of Science ®Google Scholar
• CooganPFSmithJRosenbergLStatin use and risk of colorectal cancerJ Natl Cancer Inst200799324017202111
   PubMed Web of Science ®Google Scholar
• SiddiquiAANazarioHMahgoubAPandoveSCipherDSpechlerSJThe long-term use of statins is associated with a decreased incidence of adenomatous colon polypsDigestion200979172219246916
   PubMed Web of Science ®Google Scholar
• KhuranaVBejjankiHRCalditoGOwensMWStatins reduce the risk of lung cancer in humans: A large case-control study of US veteransChest20071311282128817494779
   PubMed Web of Science ®Google Scholar
• KhuranaVShethACalditoGBarkinJSStatins reduce the risk of pancreatic cancer in humans: A case-control study of half a million veteransPancreas20073426026517312467
   PubMed Web of Science ®Google Scholar
• KhuranaVCalditoGAnkemMStatins might reduce the risk of renal cell carcinoma in humans: A case-control study of 500,000 veteransUrology20087111812218242378
   PubMed Web of Science ®Google Scholar
• EverettBMGlynnRJMacFadyenJGRidkerPMRosuvastatin in the prevention of stroke among men and women with elevated levels of C-reactive protein: Justification for the use of statins in prevention: An Intervention Trial Evaluating Rosuvastatin (JUPITER)Circulation201012114315020026779
   PubMed Web of Science ®Google Scholar
• SugawaraTAyerRZhangJHRole of statins in cerebral vasospasmActa Neurochir Suppl200810428729018457003
   PubMedGoogle Scholar
• LapchakPAHanMKThe 3-hydroxy-3-methyglutaryl A reductase inhibitor simvastatin reduces thrombolytic-induced intracerebral hemorrhage in embolized rabbitsBrain Res2009130314415019781532
   PubMed Web of Science ®Google Scholar
• SterzerPMeintzschelFRöslerALanfermannHSteinmetzHSitzerMPravastatin improves cerebral vasomotor reactivity in patients with subcortical small-vessel diseaseStroke2001322817282011739979
   PubMed Web of Science ®Google Scholar
• AmarencoPLabreucheJLipid management in the prevention of stroke: Review and updated meta-analysis of statins for stroke preventionLancet Neurol2009845346319375663
   PubMed Web of Science ®Google Scholar
• NavalNSAbdelhakTAZeballosPUrrunagaNMirskiMACarhuapomaJRPrior statin use reduces mortality in intracerebral hemorrhageNeurocrit Care2008861217701108
   PubMed Web of Science ®Google Scholar
• SillbergVAWellsGAPerryJJDo statins improve outcomes and reduce the incidence of vasospasm after aneurysmal subarachnoid hemorrhage: A meta-analysisStroke2008392622262618658040
   PubMed Web of Science ®Google Scholar
• Markovic-PleseSSinghAKSinghITherapeutic potential of statins in multiple sclerosis: Immune modulation, neuroprotection and neurorepairFuture Neurol2008315316720107624
   PubMedGoogle Scholar
• WeberMSZamvilSSStatins and demyelinationCurr Top Microbiol Immunol200831831332418219823
   PubMed Web of Science ®Google Scholar
• CoorealeJVillaAThe blood-brain-barrier in multiple sclerosis: Functional roles and therapeutic monitoringAutoimmunity20074014816017453713
   PubMed Web of Science ®Google Scholar
• IferganIWosikKCayrolRStatins reduce human blood-brain barrier permeability and restrict leukocyte migration: Relevance to multiple sclerosisAnn Neurol200660455516729291
   PubMed Web of Science ®Google Scholar
• VollmerTKeyLDurkalskiVOral simvastatin treatment in relapsing-remitting multiple sclerosisLancet20043631607160815145635
   PubMed Web of Science ®Google Scholar
• PaulFWaicziesSWuerfelJOral high-dose atorvastatin treatment in relapsing-remitting multiple sclerosisPLoS One20083e192818398457
   PubMed Web of Science ®Google Scholar
• WangQYanJChenXStatins: Multiple neuroprotective mechanisms in neurodegenerative diseasesExper Neurol4182010 [Epub ahead of print].
   Web of Science ®Google Scholar
• HarrisJRMiltonNGCholesterol in Alzheimer’s disease and other amyloidogenic disordersSubcell Biochem201051477520213540
   PubMedGoogle Scholar
• LiGShoferJBRhewICAge-varying association between statin use and incident Alzheimer’s diseaseJ Am Geriatr Soc2010581311131720533968
   PubMed Web of Science ®Google Scholar
• RosenbergPBMielkeMMTschanzJEffects of cardiovascular medications on rate of functional decline in Alzheimer diseaseAm J Geriatr Psychiatry20081688389218978249
   PubMed Web of Science ®Google Scholar
• GhoshARoyAMatrasJBrahmachariSGendelmanHEPahanKSimvastatin inhibits the activation of p21ras and prevents the loss of dopaminergic neurons in a mouse model of Parkinson’s diseaseJ Neurosci200929135431354619864567
   PubMed Web of Science ®Google Scholar
• WolozinBWangSWLiNLeeALeeTAKazisLESimvastatin is associated with a reduced incidence of dementia and Parkinson’s diseaseBMC Med2007511117198546
   PubMed Web of Science ®Google Scholar
• WahnerADBronsteinJMBordelonYMRitzBStatin use and the risk of Parkinson diseaseNeurology2008701418142218184918
   PubMed Web of Science ®Google Scholar
• KostapanosMSLiberopoulosENElisafMSStatin pleiotropy against renal injuryJ Cardiometab Syndr20094E4E919245508
   PubMedGoogle Scholar
• EllerPEllerKWolfAMAtorvastatin attenuates murine anti-glomerular basement membrane glomerulonephritisKidney Int20107742843520016464
   PubMed Web of Science ®Google Scholar
• OzsoyRCKoopmanMGKastleleinJJAriszLThe acute effect of atorvastatin on proteinuria in patients with chronic glomerulonephritisClin Nephrol20056324524915847250
   PubMed Web of Science ®Google Scholar
• TangdhanakanondKRajaREffects of statins on erythropoieten responsiveness in type-2 diabetic versus non-diabetic hemodialysis patientsClin Nephrol2010731620040345
   PubMed Web of Science ®Google Scholar
• PazikJOstrowskaJLewandowskiZRenin-angiotensin-aldosterone system inhibitors and statins prolong graft survival in post-transplant glomerulonephritisAnn Transplant200813414519034222
   PubMed Web of Science ®Google Scholar
• KandzariDERebeizAGWangASketchMHJrContrast nephropathy: An evidence-based approach to preventionAm J Cardiovasc Drugs2003339540514728060
   PubMedGoogle Scholar
• KhanalSAttallahNSmithDEStatin therapy reduces contrast-induced nephropathy: An analysis of contemporary percutaneous interventionsAm J Med200511884384916084176
   PubMed Web of Science ®Google Scholar
• PattiGNuscaAChelloMUsefulness of statin pretreatment to prevent contrast-induced nephropathy and to improve long-term outcome in patients undergoing percutaneous coronary interventionAm J Cardiol200810127928518237585
   PubMed Web of Science ®Google Scholar
• BlaschkeSViereckVSchwarzGKlingerHMGuerluekSMüllerGAAnti-inflammatory effects of atorvastatin on peripheral blood mononuclear cells and synovial fibroblasts in rheumatoid arthritisScand J Rheumatol20093823523919247848
   PubMed Web of Science ®Google Scholar
• LazzeriniPELorenziniSSelviESimvastatin inhibits cytokine production and nuclear factor-k B activation in interleukin 1-beta stimulated synoviocytes from rheumatoid arthritis patientsClin Exp Rheumatol20072569670018078616
   PubMed Web of Science ®Google Scholar
• TikizCUtukOPirildarTEffects of angiotensin-converting enzyme inhibition and statin treatment on inflammatory markers and endothelial functions in patients with long-term rheumatoid arthritisJ Rheumatol2005322095210116265685
   PubMed Web of Science ®Google Scholar
• AmitalHChodickGShalemYShalevVHMG-CoA reductase inhibitors (statins) provide primary prevention for rheumatoid arthritisArthritis Rheum200960Suppl 101174
   Google Scholar
• BauerDCHMG CoA reductase inhibitors and the skeleton: A comprehensive reviewOsteoporos Int20031427328212736772
   PubMed Web of Science ®Google Scholar
• MajimaTKomatsuYFukaoANinomiyaKMatsumuraTNakaoKShort term effects of atorvastatin on bone turnover in male patients with hypercholesterolemiaEndocr J20075414515117185879
   PubMed Web of Science ®Google Scholar
• TanriverdiHABarutASarikayaSStatins have additive effects to vertebral bone mineral density in combination with risedronate in hypercholesterolemic postmenopausal womenEur J Obstet Gynecol Reprod Biol2005120636815866088
   PubMed Web of Science ®Google Scholar
• HatzigeorgiouCJacksonJLHydroxymethylglutaryl-coenzyme A reductase inhibitors and osteoporosis: A meta-analysisOsteoporos Int20051699099815744453
   PubMed Web of Science ®Google Scholar
• MontagnaniAGonnelliSCepollaroCEffect of simvastatin treatment on bone mineral density and bone turnover in hypercholesterolemic postmenopausal women: A 1-year longitudinal studyBone20033242743312689687
   PubMed Web of Science ®Google Scholar
• LounevaNHuamanGFertalaJJiménezSAInhibition of systemic sclerosis dermal fibroblast type I collagen production and gene expression by simvastatinArthritis Rheum2006541298130816575855
   PubMed Web of Science ®Google Scholar
• KuwanaMPotential benefit of statins for vascular disease in systemic sclerosisCurr Opin Rheumatol20061859460017053504
   PubMed Web of Science ®Google Scholar
• KuwanaMOkazakiYKaburakiJLong-term beneficial effects of statins on vascular manifestations in patients with systemic sclerosisMod Rheumatol20091953053519590932
   PubMed Web of Science ®Google Scholar
• Abou-RayaAAbou-RayaSHelmiiMStatins: Potentially useful in therapy of systemic sclerosis-related Raynaud’s phenomenon and digital ulcersJ Rheumatol2009351801180818709692
   PubMed Web of Science ®Google Scholar
• RayJGDyslipidemia, statins, and venous thromboembolism: A potential risk factor and a potential treatmentCurr Opin Pulm Med2003937838412904707
   PubMed Web of Science ®Google Scholar
• AgarwalVBhardwajATongbramVWhat effect do statins have on the development of venous thromboembolism? A comprehensive meta-analysis of over 900,000 patientsInt J Clin Pract2010641375138320716146
   PubMed Web of Science ®Google Scholar
• KhemasuwanDDivietroMLTangdhanakanondKPomerantzSCEigerGStatins decrease the occurrence of venous thromboembolism in patients with cancerAm J Med2010123606520102993
   PubMed Web of Science ®Google Scholar
• KodamanPHDulebaAJStatins in the treatment of polycystic ovary syndromeSemin Reprod Med20082612713818181091
   PubMed Web of Science ®Google Scholar
• RzepczynskaIJPiotrowskiPCWongDCressABVillanuevaJDulebaAJRole of isoprenylation in simvastatin-induced inhibition of ovarian theca-interstitial growth in the ratBiol Reprod20098185085519571257
   PubMed Web of Science ®Google Scholar
• SathyapalanTKilpatrickESCoadyAMAtkinSLThe effect of atorvastatin in patients with polycystic ovary syndrome: A randomized double-blind placebo-controlled studyJ Clin Endocrinol Metab20099410310818940877
   PubMed Web of Science ®Google Scholar
• BanaszewskaBPawelczykLSpaczynskiRDziuraJDulebaAJEffects of simvastatin and oral contraceptive agent on polycystic ovary syndrome: Prospective, randomized, crossover trialJ Clin Endocrinol Metab20079245646117105841
   PubMed Web of Science ®Google Scholar
• TanJSMitchellPRochtchinaEWangJJStatins and the long-term risk of incident age-related macular degeneration: The Blue Mountains Eye StudyAm J Ophthalmol200714368568717386278
   PubMed Web of Science ®Google Scholar
• SagaraNKawajiTTakanoAEffect of pitavistatin on experimental choroidal neovascularization in ratsExp Eye Res2007841074108017418120
   PubMed Web of Science ®Google Scholar
• WilsonHLSchwartzDMBhattHRMcCullochCEDuncanJLStatin and aspirin therapy are associated with decreased rates of choroidal neovascularization among patients with age-related macular degenerationAm J Ophthalmol200413761562415059698
   PubMed Web of Science ®Google Scholar
• McGwinGJrOwsleyCCurcioCACrainRJThe association between statin use and age related maculopathyBr J Ophthalmol2003871121112512928279
   PubMed Web of Science ®Google Scholar
• KwongJCLiPRedelmeierDAInfluenza morbidity and mortality in elderly patients receiving statins: A cohort studyPLoS One20094e808719956645
   PubMed Web of Science ®Google Scholar
• FrostFJPetersonHTollestrupKSkipperBInfluenza and COPD mortality protection as pleiotropic, dose-dependent effects of statinsChest20071311006101217426203
   PubMed Web of Science ®Google Scholar
• VandermeerMThomasAKamimotoLRole of statins in preventing death among patients hospitalized with lab-confirmed influenza infectionsInfectious Diseases Society of America 47th annual meeting, 2009Boston, MAOctober 29–November 1, 2009 Abstr 706.
   Google Scholar
• JandaSYoungAFitzgeraldJMEtminanMSwistonJThe effect of statins on mortality from severe infections and sepsis: A systematic review and meta-analysisJ Crit Care201025656.e7656.e2220413251
   PubMed Web of Science ®Google Scholar
• DobeshPPKlepserDGMcGuireTRMorganCWOlsenKMReduction in mortality associated with statin therapy in patients with severe sepsisPharmacotherapy20092962163019476415
   PubMed Web of Science ®Google Scholar
• HsuJAndresDRKnasinksiVPirschJSafdarNStatins are associated with improved outcomes of bloodstream infection in solid-organ transplant recipientsEur J Clin Microbiol Infect Dis2009281343135119669657
   PubMed Web of Science ®Google Scholar
• SpanakisIKourkoumpetisTPelegALivanisGMylonakisEThe impact of statin therapy on candida colonization or infection among patients with diabetes type 2American Association of Clinical Endocrinologists 19th annual meeting, 2010Boston, MAApril 21–25, 2010 Abstr 401.
   Google Scholar